Cirrhosis and liver cancer are two of the world’s leading causes of illness and death, but they typically creep up quietly. Most people with liver disease are symptom-free until complications like ...

Sanofi multiple sclerosis drug candidate tolebrutinib boasts a key feature: the ability to reach into brain and spinal cord tissue to provide its therapeutic effect. But liver problems have been ...

Researchers report that pairing two known medicines reduced liver fibrosis in mice, offering a possible path toward scar ...

Novel non-invasive liver disease assessments (NILDAs) are effective alternatives to liver biopsy for the treatment of liver ...

A research team at the University of Missouri has treated the first cancer patient with a new nuclear medicine device that targets tumors inside the liver. The early-stage clinical trial focuses on ...

Researchers have recently created a blood test that can detect liver disease years before symptoms ever develop, helping pave the way for the diagnosis of diseases such as cirrhosis and liver cancer ...

Novel non-invasive liver disease assessments (NILDAs) can effectively replace liver biopsy for assessing liver fibrosis in ...

A recent study at the Medical University of South Carolina's (MUSC) Digestive Disease Research Core Center (DDRCC) provides insight into why physicians should be cautious when using a certain liver ...

Assessing the toxicity of food contaminants—including carcinogenic potential—is a major challenge in evaluating the risks associated with exposure. In recent years, as part of efforts to reduce animal ...

This article was reviewed by Felix Gussone, MD. Key Takeaways: Preparing properly for lab tests helps ensure your results are accurate and reliable. Some tests — ...

Many individuals assume that if their weight is normal and routine tests are within limits, their liver must be healthy. Unfortunately, this is not always true. A normal weight does not necessarily ...